Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Selectis Health (GBCS) over the last 13 years, with Q3 2025 value amounting to $7.2 million.

  • Selectis Health's Accounts Payables rose 1111.4% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 1111.4%. This contributed to the annual value of $6.6 million for FY2024, which is 874.78% up from last year.
  • Latest data reveals that Selectis Health reported Accounts Payables of $7.2 million as of Q3 2025, which was up 1111.4% from $8.0 million recorded in Q2 2025.
  • Selectis Health's Accounts Payables' 5-year high stood at $8.1 million during Q1 2025, with a 5-year trough of $2.5 million in Q3 2022.
  • For the 5-year period, Selectis Health's Accounts Payables averaged around $5.3 million, with its median value being $5.2 million (2023).
  • In the last 5 years, Selectis Health's Accounts Payables surged by 29196.57% in 2021 and then tumbled by 2803.0% in 2022.
  • Quarter analysis of 5 years shows Selectis Health's Accounts Payables stood at $4.4 million in 2021, then fell by 16.5% to $3.6 million in 2022, then surged by 65.9% to $6.0 million in 2023, then increased by 8.75% to $6.6 million in 2024, then increased by 9.55% to $7.2 million in 2025.
  • Its Accounts Payables was $7.2 million in Q3 2025, compared to $8.0 million in Q2 2025 and $8.1 million in Q1 2025.